bf/NASDAQ:OCUL_icon.jpeg

NASDAQ:OCUL

Ocular Therapeutix, Inc.

  • Stock

USD

Last Close

6.27

17/05 20:00

Market Cap

513.62M

Beta: 1.30

Volume Today

1.17M

Avg: 1.63M

PE Ratio

−5.67

PFCF: −7.52

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
66.50K
-
133.50K
100.75%
123.50K
7.49%
117.50K
4.86%
169.50K
44.26%
585.50K
245.43%
1.08M
84.03%
1.23M
13.74%
1.61M
31.54%
2.14M
32.72%
average payables
564K
-
930.50K
64.98%
1.64M
75.87%
2.04M
24.44%
2.84M
39.63%
3.27M
14.93%
3.12M
4.64%
2.99M
4.11%
3.65M
22.15%
4.86M
33.06%
4.76M
2.09%
average receivables
157K
-
299K
90.45%
261K
12.71%
221.50K
15.13%
238K
7.45%
213.50K
10.29%
1.37M
543.79%
7.40M
438.38%
16.69M
125.59%
21.23M
27.18%
23.75M
11.88%
book value per share
-20.14
-
5.51
127.36%
3.85
30.05%
2.10
45.63%
0.91
56.71%
0.94
3.74%
-0.08
108.52%
1.25
1,662.17%
1.15
8.03%
0.46
60.05%
0.00
99.77%
capex per share
-0.13
-
-0.12
9.76%
-0.08
35.33%
-0.08
1.09%
-0.29
270.30%
-0.05
82.69%
-0.05
0.26%
-0.01
72.00%
-0.02
12.91%
-0.05
209.19%
-0.00
99.85%
capex to depreciation
-0.96
-
-2.30
140.47%
-2.36
2.37%
-2.18
7.63%
-5.08
133.13%
-0.83
83.73%
-0.88
7.05%
-0.30
65.71%
-0.49
62.62%
-1.76
257.17%
-2.04
15.84%
capex to operating cash flow
0.03
-
0.06
100.87%
0.05
14.29%
0.06
7.11%
0.16
189.68%
0.04
76.53%
0.03
24.82%
0.02
45.56%
0.02
15.99%
0.06
242.18%
0.09
39.05%
capex to revenue
-1.63
-
-1.02
37.75%
-1.02
0.09%
-4.29
321.97%
-0.95
77.88%
-0.53
44.22%
-0.05
90.87%
-0.03
43.23%
-0.07
162.97%
-0.11
45.80%
cash per share
5.93
-
7.02
18.48%
4.52
35.65%
2.75
39.25%
1.44
47.51%
1.42
1.60%
1.20
15.23%
3.75
212.20%
2.15
42.75%
1.33
38.08%
0.00
99.83%
days of inventory on hand
533.46
-
153.32
71.26%
93.10
39.28%
97.44
4.66%
170.33
74.81%
149.77
12.07%
210.45
40.52%
103.55
50.79%
158.70
53.26%
159.31
0.38%
days payables outstanding
5.28K
-
2.24K
57.58%
1.74K
22.14%
2.85K
63.59%
2.33K
18.40%
513.04
77.96%
474.69
7.47%
380.41
19.86%
411.87
8.27%
303.35
26.35%
days sales outstanding
155.55
-
40.25
74.12%
48.36
20.13%
42.90
11.29%
36.87
14.06%
220.02
496.79%
256.97
16.79%
177.25
31.02%
151.16
14.72%
165.12
9.24%
debt to assets
0.13
-
0.19
48.14%
0.14
27.17%
0.21
50.77%
0.33
55.70%
0.34
4.41%
0.75
122.08%
0.22
70.39%
0.29
29.00%
0.43
49.57%
0.33
23.17%
debt to equity
-0.04
-
0.25
713.00%
0.17
32.69%
0.30
76.44%
0.69
129.08%
0.69
0.28%
-16.35
2,465.99%
0.77
104.70%
0.67
12.72%
1.82
171.08%
0.92
49.64%
dividend yield
0.06
-
0.01
83.77%
0.03
-
0.00
94.27%
0.00
-
0.00
124.48%
earnings yield
-0.34
-
-0.11
66.66%
-0.18
59.61%
-0.22
17.93%
-0.49
129.66%
-0.38
23.06%
-0.50
32.24%
-0.13
74.76%
-0.02
84.01%
-0.29
1,346.94%
-0.00
99.93%
enterprise value
23.78M
-
228.03M
858.91%
202.29M
11.29%
190.42M
5.87%
104.72M
45.01%
122.42M
16.91%
183.74M
50.08%
1.09B
492.13%
427.28M
60.73%
178.00M
58.34%
381.65B
214,306.98%
enterprise value over ebitda
-1.91
-
-8.28
334.43%
-5.32
35.77%
-4.43
16.80%
-1.70
61.52%
-2.10
23.44%
-2.17
3.34%
-17.36
699.04%
-5.48
68.44%
-2.29
58.26%
-4.63K
202,530.24%
ev to operating cash flow
-1.88
-
-11.13
491.60%
-5.99
46.12%
-5.60
6.58%
-2.07
62.95%
-2.49
19.87%
-2.37
4.77%
-20.32
757.76%
-6.52
67.91%
-2.99
54.18%
-5.43K
181,853.18%
ev to sales
295.37
-
115.59
60.87%
100.91
12.70%
54.46
46.04%
61.52
12.97%
43.47
29.34%
62.52
43.82%
9.82
84.30%
3.46
64.79%
6.59K
190,684.05%
free cash flow per share
-4.41
-
-2.04
53.73%
-1.53
25.17%
-1.45
5.28%
-2.04
40.79%
-1.34
34.19%
-1.76
31.46%
-0.90
49.21%
-0.87
2.42%
-0.82
5.73%
-0.00
99.89%
free cash flow yield
-0.34
-
-0.09
74.13%
-0.16
87.83%
-0.17
6.03%
-0.46
164.80%
-0.34
26.42%
-0.45
32.46%
-0.04
90.31%
-0.13
189.80%
-0.29
133.83%
-0.00
99.93%
graham net net
-20.63
-
5.22
125.32%
3.64
30.36%
1.83
49.65%
0.43
76.35%
0.45
3.88%
-0.56
225.38%
0.86
251.93%
0.83
2.65%
0.07
91.63%
0.00
99.07%
graham number
45.21
-
18.26
59.61%
12.18
33.31%
9.22
24.32%
6.70
27.29%
5.66
15.51%
1.89
66.56%
8.61
354.57%
1.91
77.75%
2.92
52.66%
0.00
99.84%
income quality
0.95
-
0.72
24.65%
0.85
18.66%
0.76
10.40%
0.80
4.69%
0.82
3.07%
0.90
9.43%
0.34
61.69%
10.00
2,807.04%
0.84
91.61%
0.87
3.68%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-29.26
-
-24.21
17.25%
-22.16
8.49%
-25.79
16.40%
-32.73
26.91%
-34.00
3.87%
-14.06
58.63%
-9.29
33.97%
-11.70
25.98%
-11.20
4.25%
7.27
164.87%
interest debt per share
0.98
-
1.50
52.88%
0.73
51.27%
0.70
4.53%
0.69
1.04%
0.70
0.75%
1.45
107.70%
1.07
25.75%
0.86
19.93%
0.93
7.93%
0.00
99.91%
inventory turnover
0.68
-
2.38
247.93%
3.92
64.68%
3.75
4.45%
2.14
42.79%
2.44
13.73%
1.73
28.83%
3.52
103.23%
2.30
34.75%
2.29
0.38%
invested capital
-0.04
-
0.25
713.00%
0.17
32.69%
0.30
76.44%
0.69
129.08%
0.69
0.28%
-16.35
2,465.99%
0.77
104.70%
0.67
12.72%
1.82
171.08%
0.92
49.64%
market cap
38.83M
-
250.56M
545.30%
217.80M
13.07%
207.71M
4.63%
128.24M
38.26%
151.70M
18.29%
178.83M
17.88%
1.26B
603.22%
532.46M
57.66%
216.02M
59.43%
381.76B
176,625.69%
net current asset value
-60.60M
-
56.69M
193.54%
86.27M
52.18%
46.97M
45.55%
14.05M
70.07%
19.02M
35.36%
-22.20M
216.69%
60.39M
372.04%
74.41M
23.21%
15.72M
78.88%
71.31M
353.69%
net debt to ebitda
1.21
-
0.82
32.18%
0.41
50.15%
0.40
1.47%
0.38
4.84%
0.50
31.41%
-0.06
111.54%
2.71
4,765.47%
1.35
50.17%
0.49
63.79%
1.36
179.46%
net income per share
-4.51
-
-2.69
40.37%
-1.71
36.41%
-1.80
5.34%
-2.20
22.10%
-1.51
31.18%
-1.99
31.24%
-2.63
32.27%
-0.14
94.62%
-0.83
483.34%
-0.00
99.89%
operating cash flow per share
-4.28
-
-1.92
55.07%
-1.45
24.55%
-1.37
5.62%
-1.75
27.83%
-1.29
26.26%
-1.71
32.68%
-0.88
48.56%
-0.86
2.66%
-0.78
9.64%
-0.00
99.89%
payables turnover
0.07
-
0.16
135.73%
0.21
28.44%
0.13
38.87%
0.16
22.55%
0.71
353.64%
0.77
8.08%
0.96
24.78%
0.89
7.64%
1.20
35.77%
receivables turnover
2.35
-
9.07
286.42%
7.55
16.76%
8.51
12.73%
9.90
16.36%
1.66
83.24%
1.42
14.38%
2.06
44.97%
2.41
17.26%
2.21
8.46%
research and ddevelopement to revenue
24.46
-
15.21
37.82%
14.34
5.68%
16.06
11.96%
18.55
15.52%
9.72
47.60%
1.65
83.04%
1.15
30.21%
1.04
9.78%
1.06
1.62%
return on tangible assets
-0.70
-
-0.37
47.33%
-0.36
1.65%
-0.60
65.54%
-1.14
91.70%
-0.79
30.93%
-1.14
44.61%
-0.61
46.63%
-0.05
91.35%
-0.42
705.64%
-0.32
24.60%
revenue per share
0.07
-
0.08
3.89%
0.08
1.00%
0.07
12.24%
0.05
21.76%
0.09
78.83%
0.29
206.81%
0.57
98.88%
0.67
17.58%
0.00
99.90%
roe
0.22
-
-0.49
317.97%
-0.44
9.10%
-0.86
93.73%
-2.42
182.04%
-1.61
33.66%
24.78
1,640.63%
-2.10
108.47%
-0.12
94.15%
-1.79
1,360.12%
-0.89
50.58%
roic
0.23
-
-0.37
258.09%
-0.37
0.87%
-0.65
74.66%
-1.41
116.02%
-0.94
33.43%
-1.36
44.97%
-0.45
66.93%
-0.83
85.27%
-0.64
23.28%
-0.45
29.51%
sales general and administrative to revenue
8.95
-
5.24
41.51%
5.83
11.35%
8.07
38.30%
9.44
17.05%
5.23
44.56%
1.31
74.90%
0.73
44.23%
0.63
14.57%
0.59
6.28%
shareholders equity per share
-20.14
-
5.51
127.36%
3.85
30.05%
2.10
45.63%
0.91
56.71%
0.94
3.74%
-0.08
108.52%
1.25
1,662.17%
1.15
8.03%
0.46
60.05%
0.00
99.77%
stock based compensation to revenue
3.42
-
2.65
22.58%
3.16
19.04%
3.81
20.62%
3.76
1.23%
2.07
44.89%
0.43
79.12%
0.34
20.48%
0.33
4.27%
0.31
6.50%
tangible asset value
-59.47M
-
58.70M
198.70%
89.59M
52.63%
52.01M
41.95%
26.15M
49.73%
35.88M
37.21%
-3.63M
110.12%
76.09M
2,196.28%
88.00M
15.64%
35.38M
59.80%
91.13M
157.59%
tangible book value per share
-20.14
-
5.51
127.36%
3.85
30.05%
2.10
45.63%
0.91
56.71%
0.94
3.74%
-0.08
108.52%
1.25
1,662.17%
1.15
8.03%
0.46
60.05%
0.00
99.77%
working capital
14.67M
-
70.31M
379.21%
101.61M
44.51%
61.60M
39.38%
29.91M
51.44%
47.03M
57.24%
48.14M
2.35%
219.50M
355.94%
164.96M
24.84%
98.23M
40.45%
197.34M
100.89%

All numbers in USD (except ratios and percentages)